Literature DB >> 82682

Possible role for impaired renal prostaglandin production in pathogenesis of hyporeninaemic hypoaldosteronism.

L H Norby, J Weidig, P Ramwell, L Slotkoff, W Flamenbaum.   

Abstract

A 57-year-old woman with hypertension and moderate renal insufficiency had chronic unexplained hyperkalaemia. Metabolic balance studies confirmed a diagnosis of hyporeninaemic hypoaldosteronism. Two observations suggested that impaired renal prostaglandin production contributed to the pathogenesis of the patient's disorder. Baseline renal-prostaglandin synthesis (as determined by urinary excretion of P.G.E and P.G.F) was was substantially depressed when compared with that in nine normal females. Infusion of low doses of P.G.A1 produced a significant increase in serum-aldosterone and urinary potassium excretion; it also led to a dramatic fall in blood-pressure and serum-potassium. It appears from these studies that a defect in renal prostaglandin synthesis has an important role in the pathogenesis of hyporeninaemic hypoaldosteronism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82682     DOI: 10.1016/s0140-6736(78)92275-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

2.  Formation and action of prostaglandins in the kidney.

Authors:  P C Weber; B Scherer; W Siess; E Held; J Schnermann
Journal:  Klin Wochenschr       Date:  1979-10-01

3.  Moduretic-induced metabolic acidosis and hyperkalaemia.

Authors:  H H Wan; M D Lye
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

4.  Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.

Authors:  M Schambelan; S Blake; J Sraer; M Bens; M P Nivez; F Wahbe
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.